Research output per year
Research output per year
Research activity per year
Asthma; translational research; airway inflammation; biological treatment; airway hyperresponsiveness
Asthma epidemiology; asthma diagnostics; airway inflammation; airway hyperresponsiveness; airway immunology
Currently running a investigator-initiated phase IIa study called UPSTREAM that examines the effects of blocking the immunopathway driven by TSLP in asthma. The study is a double-blind, randomized, placebo-controlled trial of Tezepelumab (anti-TSLP) in subjects with symptomatic asthma despite treatment with inhaled corticosteroids.
Participation in international medical congresses sponsored by pharma companies: Astra Zeneca, Sandoz
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review
Research output: Contribution to journal › Journal article › Research › peer-review